Elizabeth Trice Loggers

10PUBLICATIONS
89CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 08, 2025
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe, Danielle Kirkey, Isabel Lira

|Jun 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.

Vinayak Venkataraman, Hannah R Abrams, David S Shulman

|Mar 21, 2025
Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.

Michael J Wagner, Erica M Pimenta, Nathan W Sweeney

|May 04, 2024
Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study.

Elizabeth T Loggers, Rashmi Chugh, Noah Federman

|Jan 09, 2023
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406).

Lee D Cranmer, Yao Lu, Rachel S Heise

|Apr 08, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah

Pageof 2

Frequent Collaborators

4 joint publications

Seth M Pollack

3 joint publications

Michael J Wagner

3 joint publications

Robin L Jones

2 joint publications

Richard F Riedel